ICPT Annual SG&A
$176.30 M
-$54.55 M-23.63%
31 December 2022
Summary:
As of February 4, 2025, ICPT annual selling, general & administrative expenses is $176.30 million, with the most recent change of -$54.55 million (-23.63%) on December 31, 2022. During the last 3 years, it has fallen by -$141.12 million (-44.46%).ICPT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly SG&A
$45.44 M
-$7.91 M-14.82%
30 September 2023
Summary:
As of February 4, 2025, ICPT quarterly selling, general & administrative expenses is $45.44 million, with the most recent change of -$7.91 million (-14.82%) on September 30, 2023. Over the past year, it has increased by +$2.16 million (+5.00%).ICPT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM SG&A
-$8.66 B
-$61.61 M-0.72%
30 September 2023
Summary:
As of February 4, 2025, ICPT TTM selling, general & administrative expenses is -$8.66 billion, with the most recent change of -$61.61 million (-0.72%) on September 30, 2023. Over the past year, it has dropped by -$8.83 billion (-5245.89%).ICPT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.6% | +5.0% | -5245.9% |
| 3 y3 years | -44.5% | -35.7% | -2530.7% |
| 5 y5 years | -35.6% | -20.0% | -2827.8% |
ICPT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -47.0% | -53.9% | -2489.0% |
Intercept Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $45.44 M(-14.8%) | $211.73 M(+1.0%) |
| June 2023 | - | $53.35 M(-7.5%) | $209.57 M(+6.8%) |
| Mar 2023 | - | $57.66 M(+4.3%) | $196.21 M(+11.3%) |
| Dec 2022 | $176.30 M(-23.6%) | $55.29 M(+27.8%) | $176.32 M(+4.8%) |
| Sept 2022 | - | $43.27 M(+8.2%) | $168.26 M(+1.2%) |
| June 2022 | - | $39.98 M(+5.9%) | $166.26 M(-2.3%) |
| Mar 2022 | - | $37.77 M(-20.0%) | $170.15 M(-11.2%) |
| Dec 2021 | $230.85 M(-30.6%) | $47.23 M(+14.4%) | $191.66 M(+34.6%) |
| Sept 2021 | - | $41.27 M(-6.0%) | $142.39 M(-17.1%) |
| June 2021 | - | $43.88 M(-26.0%) | $171.74 M(-22.4%) |
| Mar 2021 | - | $59.27 M(-3012.6%) | $221.22 M(-15.1%) |
| Dec 2020 | $332.49 M(+4.7%) | -$2.04 M(-102.9%) | $260.50 M(-26.9%) |
| Sept 2020 | - | $70.62 M(-24.4%) | $356.22 M(-1.7%) |
| June 2020 | - | $93.36 M(-5.3%) | $362.43 M(+7.0%) |
| Mar 2020 | - | $98.56 M(+5.2%) | $338.75 M(+6.7%) |
| Dec 2019 | $317.42 M(+24.2%) | $93.68 M(+21.9%) | $317.42 M(+7.7%) |
| Sept 2019 | - | $76.83 M(+10.3%) | $294.71 M(+7.3%) |
| June 2019 | - | $69.68 M(-9.8%) | $274.69 M(+1.7%) |
| Mar 2019 | - | $77.23 M(+8.8%) | $270.23 M(+5.8%) |
| Dec 2018 | $255.47 M(-6.7%) | $70.97 M(+24.9%) | $255.47 M(-5.0%) |
| Sept 2018 | - | $56.81 M(-12.9%) | $268.84 M(-1.7%) |
| June 2018 | - | $65.22 M(+4.4%) | $273.38 M(-0.6%) |
| Mar 2018 | - | $62.47 M(-25.9%) | $275.08 M(+0.5%) |
| Dec 2017 | $273.70 M | $84.33 M(+37.5%) | $273.70 M(+3.1%) |
| Sept 2017 | - | $61.36 M(-8.3%) | $265.58 M(+3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $66.92 M(+9.6%) | $257.02 M(+7.6%) |
| Mar 2017 | - | $61.08 M(-19.9%) | $238.81 M(-12.7%) |
| Dec 2016 | $273.60 M(+129.4%) | $76.21 M(+44.3%) | $273.60 M(+6.1%) |
| Sept 2016 | - | $52.80 M(+8.4%) | $257.77 M(+12.2%) |
| June 2016 | - | $48.72 M(-49.2%) | $229.71 M(+13.7%) |
| Mar 2016 | - | $95.86 M(+58.7%) | $201.97 M(+69.4%) |
| Dec 2015 | $119.24 M(+244.6%) | $60.39 M(+144.1%) | $119.24 M(+68.6%) |
| Sept 2015 | - | $24.74 M(+18.0%) | $70.71 M(+28.3%) |
| June 2015 | - | $20.97 M(+59.6%) | $55.11 M(+30.9%) |
| Mar 2015 | - | $13.14 M(+10.8%) | $42.09 M(+21.6%) |
| Dec 2014 | $34.60 M(+163.5%) | $11.86 M(+29.8%) | $34.60 M(+26.0%) |
| Sept 2014 | - | $9.14 M(+14.8%) | $27.47 M(+28.1%) |
| June 2014 | - | $7.96 M(+40.8%) | $21.45 M(+30.9%) |
| Mar 2014 | - | $5.65 M(+19.5%) | $16.39 M(+24.8%) |
| Dec 2013 | $13.13 M(+153.7%) | $4.73 M(+51.8%) | $13.13 M(+24.1%) |
| Sept 2013 | - | $3.12 M(+7.8%) | $10.59 M(+25.1%) |
| June 2013 | - | $2.89 M(+20.6%) | $8.46 M(+29.9%) |
| Mar 2013 | - | $2.40 M(+9.8%) | $6.51 M(+25.8%) |
| Dec 2012 | $5.18 M(+23.0%) | $2.18 M(+120.3%) | $5.18 M(+28.5%) |
| Sept 2012 | - | $991.10 K(+5.0%) | $4.03 M(-3.9%) |
| June 2012 | - | $943.90 K(-10.9%) | $4.19 M(+29.1%) |
| Mar 2012 | - | $1.06 M(+2.3%) | $3.25 M(+48.4%) |
| Dec 2011 | $4.21 M(+15.5%) | $1.04 M(-10.3%) | $2.19 M(+89.7%) |
| Sept 2011 | - | $1.15 M | $1.15 M |
| Dec 2010 | $3.64 M | - | - |
FAQ
- What is Intercept Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual SG&A year-on-year change?
- What is Intercept Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly SG&A year-on-year change?
- What is Intercept Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM SG&A year-on-year change?
What is Intercept Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ICPT is $176.30 M
What is the all time high annual SG&A for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual selling, general & administrative expenses is $332.49 M
What is Intercept Pharmaceuticals annual SG&A year-on-year change?
Over the past year, ICPT annual selling, general & administrative expenses has changed by -$54.55 M (-23.63%)
What is Intercept Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ICPT is $45.44 M
What is the all time high quarterly SG&A for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $98.56 M
What is Intercept Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ICPT quarterly selling, general & administrative expenses has changed by +$2.16 M (+5.00%)
What is Intercept Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ICPT is -$8.66 B
What is the all time high TTM SG&A for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM selling, general & administrative expenses is $362.43 M
What is Intercept Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ICPT TTM selling, general & administrative expenses has changed by -$8.83 B (-5245.89%)